Mladsi D, Zhou X, Mader G, Sanon M, Wang J, Barnett C, Willey C, Seliger S. Mortality risk in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2024 Feb 16;25(1):56. doi: 10.1186/s12882-024-03484-3
Danese D, Goss D, Romano (DeMuro) C, Gupta C. Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study. BMC Nephrol. 2023 Oct 26;24(1):319. doi: 10.1186/s12882-023-03365-1
Mader G, Mladsi D, Sanon M, Purser M, Barnett CL, Oberdhan D, Watnick T, Seliger S. A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease. BMC Nephrol. 2022 Oct 18;23(1):334. doi: 10.1186/s12882-022-02956-8
Mansfield C, Sutphin J, Boeri M. Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question. Health Econ. 2020 Oct;29(10):1307-15. doi: 10.1002/hec.4124
Heidenreich S, Watson V, Ryan M, Phimister E. Decision heuristic or preference? Attribute non-attendance in discrete choice problems. Health Econ. 2018 Jan;27(1):157-71. doi: 10.1002/hec.3524
Tsuchiya A, Watson V. Re-thinking “the different perspectives that can be used when eliciting preferences in health". Health Econ. 2017 Dec;26(12):e103-7. doi: 10.1002/hec.3480
Krucien N, Watson V, Ryan M. Is best-worst scaling suitable for health state valuation? A comparison with discrete choice experiments. Health Econ. 2017 Dec;26(12):e1-e16. doi: 10.1002/hec.3459
Watson V, Becker F, de Bekker-Grob E. Discrete choice experiment response rates: a meta-analysis. Health Econ. 2017 Jun;26(6):810-7. doi: 10.1002/hec.3354
Montserrat-Capdevila J, Godoy P, Marsal JR, Barbe-Illa F. Factors associated with influenza immunization in primary care health workers. Gac Sanit. 2015 Sep;29(5):383-6. doi: 10.1016/j.gaceta.2015.02.004
Soler-Gonzalez J, Marsal JR, Serna C, Real J, Cruz I, Lopez A. Poorer diabetes control among the immigrant population than among the autochthonous population. Gac Sanit. 2013 Jan;27(1):19-25. doi: 10.1016/j.gaceta.2011.12.015
Forns J, Julvez J, Garcia-Esteban R, Guxens M, Ferrer M, Grellier J, Vrijheid M, Sunyer J. Maternal intelligence-mental health and child neuropsychological development at age 14 months. Gac Sanit. 2012 Sep;26(5):397-404. doi: 10.1016/j.gaceta.2011.10.011
Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Houser KA, Keyes V. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012 Jun;21(6):633-52.
Ryan M, Watson V. Comparing welfare estimates from payment card contingent valuation and discrete choice experiments. Health Econ. 2009 Apr;18(4):389-401. doi: 10.1002/hec.1364
Ryan M, Watson V, Entwistle V. Rationalising the 'irrational': a think aloud study of discrete choice experiment responses. Health Econ. 2009 Mar;18(3):321-36. doi: 10.1002/hec.1369
Ferrer C, Garcia-Esteban R, Mendez M, Romieu I, Torrent M, Sunyer J. Social determinants of dietary patterns during pregnancy. Gac Sanit. 2009 Jan;23(1):38-43. doi: 10.1016/j.gaceta.2008.05.004
Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.
Fortuny J, Silverman D, Malats N, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Dosemeci M, Kogevinas M. Use of analgesics and aspirin in a Spanish multicenter study. Gac Sanit. 2005 Jul;19(4):316-20. doi: 10.1157/13078041
Garcia-Albeniz X, Guerra-Gutierrez F, Ortega-Martinez R, Sanchez-Víllegas A, Martinez-Gonzalez MA. Tobacco consumption in university graduates. Gac Sanit. 2004 Mar;18(2):108-17.
Bonfill X, Roura P, Moreno C, Rivero E, Rué M. Cancer mortality in the counties of Catalonia, Spain (1983-1989). Gac Sanit. 1997 Feb;11(2):74-82.
Portella E, Rivero E, Carrillo E, Colom D, Murillo C, Murillo J. Influence of municipal registry errors on the identification of a sample. Gac Sanit. 1991;5(25):183-4.